Issuer Credit Research

Issuer Summary: UPL Limited / UPL Corporation

Issuer Summary: UPL Limited / UPL Corporation

Report date: 2026-05-13

This report treats India-listed UPL Limited together with UPL Corporation Ltd., its key subsidiary and overseas crop protection platform, as the UPL Group. UPL is not a fertilizer producer or fertilizer cooperative. Its core businesses are crop protection, seeds, specialty chemicals, and agricultural solutions. As such, fertilizer and resource shocks stemming from Middle East developments should be viewed for UPL not as a direct shortage of fertilizer feedstock, but as a secondary credit risk transmitted through farmers’ purchasing power, planting and fertilization behavior, logistics costs, working capital, and region-by-region sales collection.

Unless otherwise stated, the financial figures in this report are presented on a consolidated UPL Limited basis. By contrast, issues relating to foreign-currency bonds, ratings, and bondholders are assessed mainly with reference to UPL Corporation Ltd., the rated entity. Even if consolidated UPL profitability improves, this does not by itself mean that the legal protections, guarantees, collateral, subsidiary restrictions, and covenants for UPL Corp. bonds are sufficient. Avoiding confusion between these two layers is a premise of this report.

FY2026 figures are reflected after reviewing the audited consolidated and standalone Financial Results, Press Release, and Investor Presentation PDFs dated May 11, 2026. Auditor B S R & Co. LLP issued an unmodified opinion on the FY2026 consolidated and standalone financial results. Many FY2026 items that were left unconfirmed in the prior report—operating cash flow, cash, short- and long-term debt, working capital, and segment figures—have been replaced in this report with official disclosure-based figures. On the other hand, the FY2026 Annual Report, UPL Corp.’s standalone bond-issuer financials, unused committed lines, bond terms, scope of guarantees, and detailed maturity ladder have not yet been obtained, and remain items to verify before investing in any specific bond.

1. Business Snapshot and Recent Developments

UPL is an India-based global agricultural inputs company. It sells into agricultural markets in more than 140 countries, combining post-patent crop protection products with seeds, seed treatment, post-harvest solutions, and specialty chemicals. Rating agency materials treat UPL Corporation Ltd. as a wholly owned subsidiary of UPL Limited and as the main issuer and rated entity providing access to the overseas crop protection business. For bond investors, therefore, the basic analytical unit has two layers: the operating and financial resilience of consolidated UPL Limited, and the extent to which UPL Corp. creditors can access that consolidated cash flow.

The most recent change is that earnings and the balance sheet have recovered from the sharp FY2024 downturn through FY2025 and FY2026. FY2025 revenue was INR 466.37 billion, EBITDA was INR 81.24 billion, EBITDA margin was 17.4%, and net profit attributable to shareholders was INR 8.98 billion, returning the company to profit after the FY2024 net loss. FY2026, based on the audited consolidated Financial Results and Investor Presentation, recorded revenue of INR 518.39 billion, EBITDA of INR 95.88 billion, EBITDA margin of 18.5%, profit before tax of INR 31.57 billion, net profit of INR 22.20 billion, and net profit attributable to shareholders of INR 19.21 billion. Q4 FY2026 was also strong, with revenue of INR 183.35 billion, EBITDA of INR 36.46 billion, and net profit attributable to shareholders of INR 10.61 billion. The company explains that in FY2026 it exceeded guidance on three metrics: revenue, EBITDA, and gearing.

The important point, however, is not to conclude that “recovery means low risk.” FY2026 revenue growth was composed of volume +8%, price -3%, and FX +6%, meaning that the earnings recovery was not simply a function of price recovery. Operating cash flow remained positive at INR 78.55 billion, but declined from INR 101.51 billion in FY2025, while working capital changes represented a cash outflow of INR 12.24 billion in FY2026. UPL’s performance over the past several years has been heavily influenced by agrochemical prices, channel inventories, farmer credit including in Latin America, raw materials and logistics, and working capital. Strong FY2026 earnings support credit quality, but the next credit judgment depends on whether EBITDA recovery can translate steadily into operating cash flow, free cash flow, and debt reduction from FY2027 onward.

2. Industry Position and Franchise Strength

UPL’s strength lies in its scale and diversification, rather than dependence on a single country or single product. Fitch positions UPL as the world’s largest pure-play post-patent crop protection company by 2024 revenue and positively assesses its product portfolio, geographic diversification, and backward integration. S&P also describes UPL as the world’s fifth-largest agricultural solutions company, covering seeds, crop protection, storage, and post-harvest solutions.

This business base has two credit implications. First, diversification across sales regions, crops, and products reduces the risk that the whole group will be derailed by weather disruption or policy change in a single country. Second, the combination of in-house manufacturing and external procurement allows UPL to manage cost and supply stability to some extent, rather than being wholly dependent on external supply from China or elsewhere. At the same time, post-patent agrochemicals are more exposed to price competition than the patented-product portfolios of top-tier global chemical companies. If Chinese manufacturing overcapacity and weak agrochemical price indices persist, margins may struggle to return to prior peaks even if sales volumes grow.

In this respect, UPL’s franchise cannot be explained simply as a “defensive agricultural essential.” Agrochemicals are essential to protecting crop yields, but if farmers’ cash flow deteriorates, purchase timing, product mix, distributor credit terms, and inventory levels can all be affected. In markets such as Latin America, where large-scale farmers, sales financing, and receivables can become material, cash conversion may deteriorate before underlying demand does.

When assessing industry position, it is necessary to distinguish between R&D-led crop science companies with patented products and companies that supply post-patent agrochemicals at scale and low cost. For the former, new active ingredients, brands, regulatory data, and intellectual property tend to support pricing power. For the latter, competitiveness depends on the number of products, registration network, manufacturing cost, procurement, regional sales networks, and working capital management. UPL has scale within the latter group and the ability to sell across a wide range of regions, which is a strength. However, if price competition intensifies, scale alone may not be enough to protect margins.

The FY2024 industry stress was not merely a company-specific factor. It reflected a combination of excess agrochemical channel inventories, lower agricultural commodity prices, Chinese supply capacity, and weaker profitability among farmer customers. For a broad-based distributor such as UPL, these pressures first appear as weaker orders and lower prices, and then spread into inventory valuation, utilization rates, receivables collection, and credit costs. The FY2025-FY2026 recovery indicates that inventory adjustment has progressed, but the same structure could reappear in the next downside cycle.

Being an Indian company provides some advantages in capital market access and manufacturing footprint. S&P viewed Indian supply in 2025 as potentially relatively advantaged versus Chinese supply under the U.S. tariff environment at the time. However, this is a policy-dependent relative advantage, not permanent pricing power. Changes in tariffs, export controls, registration systems, environmental regulation, chemical safety incidents, or currency movements could quickly affect margins and inventory planning.

This industry-positioning lens is also important in relation to Middle East developments. Higher fertilizer prices increase farmers’ total input costs. If farmers reduce fertilizer application, expected yields decline, and spending on crop protection also tends to become more cautious. Conversely, if crop prices rise by more than the increase in fertilizer costs, planting incentives and demand for crop protection products may be supported. Middle East risk therefore should not be read one-directionally as “higher fertilizer prices are bad for UPL.” It needs to be assessed together with farmer cash margins, planted area, crop prices, and region-specific subsidy systems.

3. Segment Assessment

In its audited financial statements, UPL presents three reportable segments: crop protection, Seeds & Post harvest, and Non agro. In management commentary, it also presents four platforms: UPL Corp, UPL Sustainable Agri Solutions, Advanta, and Superform Chemistries. For credit analysis, the audited segment table is used to assess profitability by business type close to statutory disclosure, while platform-level disclosures are used to understand post-reorganization management units, the importance of UPL Corp. as the bond issuer, and capital allocation to Advanta and Superform. The two approaches are not perfectly identical, so they should not be simply added together and treated as creditor recovery resources.

Category FY2026 revenue FY2026 segment result / EBITDA Margin Credit interpretation
Crop protection (audited segment) INR 423.99 billion INR 57.38 billion 13.5% The group’s core business. Volume recovery and lower costs are supportive, but the segment is most sensitive to price competition, active ingredients and intermediates, inventory, and receivables collection.
Seeds & Post harvest (audited segment) INR 68.30 billion INR 14.25 billion 20.9% Shows higher profitability than crop protection, but has issues relating to varieties, regions, selling seasons, and minority interests.
Non agro (audited segment) INR 28.03 billion INR 3.44 billion 12.3% A supplementary earnings source from specialty chemicals such as Superform. Monitor raw materials, the chemicals cycle, and demand from external customers.
UPL Corp (management platform) INR 382.77 billion EBITDA INR 60.08 billion 15.7% The overseas crop protection platform most important for bond investors. FY2026 revenue was up 11% and EBITDA up 20%.
UPL SAS (management platform) INR 32.12 billion EBITDA INR 5.48 billion 17.1% India crop protection business. Revenue was broadly flat, but profitability improved through portfolio rationalization and new products.
Advanta (management platform) INR 68.37 billion EBITDA INR 17.25 billion 25.2% Revenue was up 23% and EBITDA up 30%, led by field corn and other products. Growth is attractive, but minority interests and capital transactions require attention.
Superform (management platform) INR 102.98 billion EBITDA INR 12.58 billion 12.2% Specialty chemicals. Growth in super specialty chemicals and mix improvement are supportive, but the platform also imports non-agricultural chemicals-cycle exposure.

Note: UPL Corp in the table above is a management platform disclosed by the company, not the audited standalone issuer financials of UPL Corporation Ltd. Improvements in UPL Corp platform revenue and EBITDA are therefore important supporting evidence for UPL Corp. bonds, but do not directly demonstrate guarantees, collateral, restrictive covenants, or legal access to subsidiary cash.

Crop protection is large in revenue terms, and the global sales network and breadth of products are the main credit supports. However, this business is affected by the supply of agrochemical active ingredients and intermediates, manufacturing utilization, inventory valuation, and selling prices. In FY2026, UPL Corp. revenue increased 11% and EBITDA increased 20%, indicating that the profitability of the core platform relevant to bond investors has recovered. On the other hand, the Investor Presentation shows that FY2026 revenue growth was volume-led and that price was a negative factor. Accordingly, the earnings recovery was supported substantially by volume, utilization, input costs, and FX, and cannot yet be viewed as a full recovery in pricing power.

Seeds/Advanta has more pronounced variety, regional, and selling-season characteristics than crop protection, and FY2026 revenue and EBITDA growth was centered on field corn. Its high EBITDA margin lifts group profitability. However, the FY2025 sale of a minority stake in Advanta was positive as a funding source for deleveraging, while also increasing the need for bondholders to monitor future group structure, minority interests, and cash flow attribution. On the specialty chemicals side, including Superform Chemistries, the business can be affected by non-agricultural chemicals cycles, raw materials, and regulation. In FY2026, revenue rose only modestly, but EBITDA increased 10%, with mix and input costs supporting profitability.

Middle East developments do not affect these segments directly with equal intensity. Because UPL is not a fertilizer producer, it differs from fertilizer companies that face potential production stoppages due to LNG, ammonia, phosphate rock, DAP, or urea shortages. However, if fertilizer prices and supply pressures constrain farmers’ input budgets, they can affect the timing of crop protection purchases and product choice, and weaken UPL’s cash flow through receivables and inventory. In other words, Middle East risk is more likely to appear first in farmer and distributor credit, region-specific sales collection, and working capital than directly in UPL’s income statement.

This is easier to understand in three layers. The first layer is the risk of disruption to fertilizer feedstocks and fertilizer production itself. This has low direct relevance to UPL. UPL does not primarily manufacture and sell urea, DAP, or NPK, and its business model does not directly depend on fertilizer manufacturers’ capacity utilization or recovery of government subsidies. The second layer is risk relating to UPL’s own crop protection raw materials, chemical intermediates, packaging materials, logistics, and inventory build. If Middle East developments push up oil, gas, and maritime logistics costs, these will affect UPL’s manufacturing, procurement, and distribution costs separately from fertilizer. This channel has moderate direct relevance. The third layer is farmer purchasing power, distributor credit, regional demand, and receivables collection. This is an indirect accounting channel, but it may be the most important credit channel.

The direct risk to crop protection raw materials is less straightforward than fertilizer feedstock risk. Agrochemical active ingredients and intermediates are procured from multiple regions, including China and India, and each product differs in terms of active ingredient, solvent, packaging, and transport requirements. Even if the Middle East is not a major source of a particular active ingredient, higher oil and gas prices or seaborne freight rates can spread into synthetic chemical costs, inventory holding, and supply lead times. UPL’s backward integration can partly reduce reliance on external procurement, but raising manufacturing utilization requires demand visibility and inventory funding. If the company overproduces, it carries the next price-downturn risk.

The Seeds/Advanta channel differs somewhat in response to fertilizer price shocks. Seeds are tied closely to pre-planting decisions. If farmers alter planted acreage or move from higher-value seeds to lower-priced seeds, volumes and mix can be affected. At the same time, seed demand is highly essential as long as farmers continue planting, and the purchase point comes earlier than crop protection. Therefore, even if fertilizer prices surge, seed demand does not disappear immediately, but farmers’ crop selection and price sensitivity across the full input package increase.

The Specialty/Superform side may be affected not only by agricultural demand but also by the chemicals cycle and customer industries. Oil and petrochemical price movements arising from Middle East developments may push up costs, while pass-through power varies by product. FY2026 revenue and EBITDA have been confirmed, but platform-level assets, debt, working capital, and capex have not been broken out. The extent to which each platform supports deleveraging therefore remains a point to verify in the next update.

4. Financial Profile and Analysis

UPL’s financial profile has clearly improved from the FY2024 trough through FY2026. The main changes are revenue recovery, normalization of EBITDA margin, a shift from net loss to profit, net debt reduction, and the fact that the capital structure was not significantly impaired even after perpetual bond redemption. FY2026 net debt/EBITDA was below 1.6x on the company’s disclosure, which on the surface is not weak for a BB-rated crop protection company. However, FY2026 operating cash flow declined from FY2025 and working capital turned into a cash outflow, so there remains a gap between earnings improvement and cash conversion.

Unless a row explicitly states “USD,” the table below is presented in INR billion. EBITDA, FCFF, FCFE, gross debt, net debt, net debt/EBITDA, and cash and cash equivalents including current investments are mainly company-disclosed indicators from the May 11, 2026 Investor Presentation, and are not rating agency-adjusted metrics. PAT, operating cash flow, finance costs, and similar items have been cross-checked against the audited Financial Results. For cash, the Investor Presentation’s “cash and cash equivalents including current investments” differs from “cash and cash equivalents” in the audited Financial Results, so the definition difference should be kept in mind when assessing liquidity.

Metric FY2024 FY2025 FY2026 Source / note Credit interpretation
Revenue INR 431.0 billion INR 466.37 billion INR 518.39 billion FY2024-FY2025 from FY2025 release; FY2026 from audited Financial Results / Investor Presentation. FY2026 was volume +8%, price -3%, FX +6%. Growth was driven mainly by volume, FX, and utilization, not price recovery.
EBITDA INR 55.2 billion INR 81.24 billion INR 95.88 billion Company-disclosed EBITDA. Cost management and volume recovery since FY2025 are reflected in earnings.
EBITDA margin 12.8% 17.4% 18.5% Company disclosure. May differ from rating agency-adjusted margin. Significantly improved, but prior peak margins should not be assumed under post-patent agrochemical price competition.
PBT Unconfirmed INR 8.30 billion INR 31.57 billion Audited Financial Results / Investor Presentation. PBT increased about fourfold, supported by EBITDA growth, lower finance costs, and improvement in exceptional items.
PAT Unconfirmed INR 8.20 billion INR 22.20 billion Audited Financial Results. Net profit recovered substantially, though normalization of tax and minority interests create a difference from PATMI.
PATMI Unconfirmed INR 8.98 billion INR 19.21 billion Investor Presentation. Profit attributable to shareholders also increased 114%. Operational PATMI excluding the FY2025 tax refund impact was INR 18.60 billion.
Operating cash flow INR 29.37 billion INR 101.51 billion INR 78.55 billion FY2026 Financial Results cash flow statement. Positive, but lower than FY2025. Working capital outflow partly absorbed the EBITDA improvement.
FCFF -INR 7.54 billion INR 75.55 billion INR 55.93 billion Investor Presentation. Positive after capex and investments. The decline from FY2025 is a monitoring point.
FCFE -INR 38.90 billion INR 45.28 billion INR 32.26 billion Investor Presentation. Operating cash flow measure excluding borrowings, rights issue, perpetual bond repayment, and dividends. There is funding for debt repayment, but the amount narrowed from FY2025.
Gross debt Unconfirmed USD 3.174 billion USD 2.325 billion Investor Presentation. FY2025 includes perpetual bonds. Reduced by USD 0.85 billion in FY2026. The USD 0.5 billion repayment in March 2026 was significant.
Net debt USD 2.66 billion USD 2.021 billion USD 1.616 billion Investor Presentation. FY2025 includes perpetual bonds. Net debt declined by USD 0.405 billion. The reduction is larger after adjusting for FX effects.
Cash and cash equivalents incl. current investments Unconfirmed INR 98.56 billion INR 67.20 billion Investor Presentation. Cash and cash equivalents in the Financial Results were INR 59.75 billion. Cash declined. Debt reduction and lower liquidity buffer need to be assessed together.
Short-term debt Unconfirmed INR 54.51 billion INR 65.11 billion Investor Presentation. Short-term debt increased. Handling the USD 0.5 billion December 2026 maturity is important.
Long-term debt Unconfirmed INR 182.63 billion INR 155.35 billion Investor Presentation. Long-term debt declined. Total debt reduction is clear.
Net debt/EBITDA Unconfirmed 2.1x Below 1.6x Investor Presentation. The company-disclosed ratio improved. It may differ from rating agency-adjusted ratios.
Net working capital days Unconfirmed 53 days 57 days Investor Presentation. Deteriorated by four days from FY2025. The level remains within range, but shows cash absorption during revenue recovery.

As shown in the table, the financial profile has recovered. However, company-disclosed net debt/EBITDA and rating agency-adjusted Debt/EBITDA are not the same. In 2025, S&P placed UPL Corp.’s adjusted Debt/EBITDA at 3.5x and expected improvement from FY2026 onward, while assessing liquidity as “less than adequate.” Fitch also noted that EBITDA leverage had improved in FY2025, but saw a possibility that the FY2026 working-capital cycle would lengthen again. FY2026 actual results partially reduce this concern, but because working capital was in fact a cash outflow, how the rating agencies update cash conversion and liquidity remains important.

FY2026 cash conversion was strong but not complete. In the audited cash flow statement, adjusted profit before operating working capital improved, but inventories increased by INR 23.60 billion and trade receivables and other assets increased by INR 45.00 billion. An INR 56.87 billion increase in trade payables and other liabilities partly offset this, but working capital overall was a cash outflow. The Investor Presentation also shows inventory increasing from INR 103.16 billion to INR 126.76 billion, receivables from INR 130.67 billion to INR 165.28 billion, and payables from INR 166.19 billion to INR 210.85 billion. UPL explains this as reflecting higher sales, preparation for Q1, and a response to the credit environment. From a bond investor perspective, the most important point is whether receivables collection and inventory turnover are maintained in FY2027.

The quality of funding also requires attention because non-recourse receivables factoring is large. The company disclosed that, as a risk management measure, receivables of INR 102.31 billion, or USD 1.079 billion, had been factored to banks on a non-recourse basis as of end-March 2026. This lightens reported receivables and borrowings and supports seasonal funding. However, if factoring market availability or terms deteriorate, the impact would feed back into working capital and liquidity. Therefore, UPL’s operating cash flow should be assessed not only by reported receivables, but together with factoring usage and customer credit quality.

Profitability quality cannot be assessed simply by margin improvement either. FY2026 contribution margin improved 220 bps to 41.2%, and EBITDA margin improved 110 bps to 18.5%. The company cites higher capacity utilization, lower input costs, business portfolio rationalization, and Advanta growth as drivers. On the other hand, the price component of revenue growth was negative, meaning the post-patent agrochemical pricing environment has not fully recovered. If volume and lower costs were the main drivers, margins may narrow again if demand recovery stalls or raw material and logistics costs rise again.

Currency and definitions are also important in leverage assessment. Company-disclosed gross debt and net debt are shown in U.S. dollar terms, while revenue and EBITDA are disclosed in rupees. USD/INR moved from 85.48 at end-March 2025 to 94.84 at end-March 2026, and the company shows net debt reduction after adjusting for FX impact at INR 34.55 billion. UPL has global revenue and therefore some natural hedge, but the Debt Profile shows that debt currency as of end-March 2026 was heavily concentrated in U.S. dollars. FX movements, foreign-currency liquidity, hedging, and the currency of regional cash flows remain items to verify at both issuer and bondholder levels.

FY2026 results may have moved in a better direction than rating agencies’ FY2025 assumptions. The audited materials and investor presentation confirmed operating cash flow, FCFF, FCFE, cash, short- and long-term debt, and working capital, which were unconfirmed in the previous report. At this point, improved profitability and lower debt clearly support credit quality, but working capital, factoring, the December 2026 maturity, unused lines, and the standalone debt structure of UPL Corp. remain constraints.

5. Structural Considerations for Bondholders

For bondholders, the relationship between UPL Limited and UPL Corp. is important. In S&P and Fitch materials, UPL Corp. is treated as a wholly owned subsidiary of UPL Limited, and the rating is closely linked to parent UPL’s consolidated credit quality. Fitch aligns UPL Corp.’s rating with parent credit quality and views UPL’s strategic and business incentive to support UPL Corp. as high. S&P also rates UPL Corp.’s senior unsecured bonds at the same BB level as the issuer credit rating and explains that subordination risk is limited because secured debt was low as of end-March 2025.

Even so, an issuer report cannot leave structural risk unexamined. The FY2026 Financial Results note that the board approved a Composite Scheme of Arrangement on February 20, 2026. The scheme involves merging UPL Sustainable Agri Solutions Limited, namely the India Crop Protection business, into UPL Limited, then demerging the India Crop Protection business into UPL Global Sustainable Agri Solutions Limited, and merging UPL Crop Protection Holdings Limited into UPL Global. The appointed date for the UPL SAS merger is April 1, 2026, but the scheme requires approval from shareholders, regulators, and the NCLT, and is not yet reflected in the audited Financial Results for the year ended March 2026.

The key structural issue is that “UPL Corp. is a major operating company of the consolidated group” and “the legal protection for a specific bond is the same as consolidated credit quality” are not the same statement. Rating agencies strongly link UPL Corp. to consolidated UPL Limited based on parent-subsidiary relationships, strategic integration, integrated funding, and the importance of the overseas crop protection business. However, bondholder recovery is affected by the bond issuer, guarantors, collateral, debt restrictions, dividends, loans and royalties from subsidiaries, local regulation, taxes, and minority interests. Even if consolidated EBITDA increases, if cash is trapped in non-guaranteed subsidiaries, bondholders’ effective access can be weak.

In UPL’s case, the Advanta stake sale supported deleveraging, but also complicates the attribution of future cash flows and the treatment of minority interests. The scheme reviewed in this report also has significance for the company in clarifying business management units and reorganizing the functions of the India crop protection business and UPL Global. From a creditor perspective, however, it is necessary to confirm asset transfers, debt transfers, replacement or transfer of guarantees, the scope of the restricted group, and intercompany funding restrictions. At this stage, it is possible to refer to the fact that rating agencies rate UPL Corp. senior unsecured notes at BB, the same level as the issuer rating, but that is not a substitute for bond documentation.

This report treats the BB rating on UPL Corp. senior unsecured notes and the rating agencies’ view that structural subordination is limited as supporting credit factors. However, bond-level covenants, guarantors, change of control, restricted payments, asset sale provisions, cross-default provisions, and other terms remain unconfirmed. For investment in a specific bond, the offering circular, indenture, or trust deed needs to be reviewed.

6. Capital Structure, Liquidity and Funding

UPL’s capital structure has improved. FY2026-end gross debt was USD 2.325 billion and net debt was USD 1.616 billion, down by USD 0.850 billion and USD 0.405 billion, respectively, from FY2025-end. The company states that it repaid USD 0.5 billion of debt in March 2026 and also proactively worked on refinancing the USD 0.5 billion sustainability-linked loan bonds maturing in December 2026. In a recovery from the bottom of the agrochemical cycle, visible debt repayment, not just earnings recovery, has credit value.

The following table shows company-disclosed figures based on the FY2026 debt profile and balance sheet analysis in the Investor Presentation. U.S. dollar conversion is based on USD/INR of 85.48 at end-March 2025 and 94.84 at end-March 2026 as stated in the same materials, and may not match adjusted debt, cash, or liquidity sources used by rating agencies.

Liquidity / capital structure item End-March 2025 End-March 2026 Credit interpretation
Gross debt USD 3.174 billion USD 2.325 billion Reduced by USD 0.85 billion. Note that the FY2025 definition includes perpetual bonds.
Net debt USD 2.021 billion USD 1.616 billion Reduced by USD 0.405 billion. Excluding FX effects, the reduction is larger.
Cash and cash equivalents incl. current investments USD 1.153 billion USD 0.709 billion Cash declined. Debt repayment and reduced liquidity buffer need to be assessed together.
Short-term debt USD 638 million USD 687 million Short-term debt increased modestly. Handling the December 2026 maturity is important.
Long-term debt USD 2.137 billion USD 1.638 billion Long-term debt reduction is clear.
Debt security profile Unconfirmed 99.1% unsecured / 0.9% secured Secured debt appears limited, but individual bond terms remain unconfirmed.
Debt currency profile Unconfirmed USD 97.8%, BRL 2.1%, RMB 0.1% Debt is heavily concentrated in U.S. dollars. Foreign-currency cash flow and hedging need to be verified.

At the same time, liquidity quality still needs to be assessed cautiously. In May 2025, S&P estimated UPL Corp.’s 12-month liquidity sources/uses at below 1.2x, and cited seasonal working capital swings, short-term debt, capex, and perpetual securities redemption as uses of liquidity. FY2026 actual results improved from that point, but unused committed lines, 12-month sources/uses, bank-by-bank credit lines, and bond-by-bond maturities and terms have not yet been confirmed in this report. The company’s Debt Profile shows a USD 0.5 billion maturity in December 2026, and the terms on which this is refinanced will drive near-term liquidity assessment.

When assessing UPL’s liquidity, the timing of funding sources and uses is more important than single-year net debt reduction. Agricultural inputs companies build inventory before the selling season and collect receivables after sales, so EBITDA in the income statement and funding headroom do not always move together. In FY2026, net working capital days increased from 53 days to 57 days, DIO from 81 days to 89 days, DSO from 102 days to 116 days, and DPO from 130 days to 148 days. The company describes net working capital days as rangebound, but inventory, receivables, and payables have all increased materially, making it clear that revenue growth has come with a funding burden.

Factoring is also central to liquidity assessment. Non-recourse receivables factoring was INR 102.31 billion, or USD 1.079 billion, at end-March 2026, up from INR 88.75 billion, or USD 1.038 billion, at end-March 2025. If non-recourse, this is less visible as borrowing, but it shows dependence on sales financing and bank markets. If farmer credit or distributor credit deteriorates and banks tighten factoring terms, UPL may need to carry inventory and receivables on its own balance sheet. This is why positive FY2026 operating cash flow alone does not justify treating liquidity as an unconditional strength.

On refinancing, UPL has a track record of access to domestic and international bank and bond markets. This is an important support for a BB issuer. However, a record of market access does not mean unconditional liquidity under high stress. If agrochemical cycle deterioration, Middle East-related logistics and fertilizer shocks, rupee depreciation, and global credit market risk-off occur together, conditions for rolling short-term borrowings, factoring, and foreign-currency bond refinancing could deteriorate. Therefore, in the next update, 12-month sources/uses, 18-24 month maturities, short-term debt facilities, and the secured debt ratio should be reviewed together with rating agency reviews after FY2026 results.

Interest burden has improved. In the Investor Presentation’s P&L bridge, FY2026 net finance costs were INR 25.77 billion, down 17% from INR 30.90 billion in FY2025. Finance costs in the audited financial results were INR 34.01 billion, down from INR 36.27 billion in FY2025. This reflects the effect of debt repayment. However, given the concentration of debt in U.S. dollars, refinancing conditions for the December 2026 maturity, and future short-term borrowing rates, it is difficult to conclude that interest-paying capacity has structurally moved into a safe zone.

7. Rating Agency View

In May 2025, S&P revised the outlook on UPL Corp. from Negative to Stable and affirmed the long-term issuer credit rating at BB. S&P’s main view was that gradual recovery in the global agrochemical industry, debt repayment, earnings growth, maturity management, and working capital discipline would improve FFO/debt over the next 24 months. At the same time, S&P left as risks large working capital swings, Latin America receivables, less-than-adequate liquidity, and delayed industry recovery.

In June 2025, Fitch also revised the outlook on UPL Corp. from Negative to Stable and affirmed the Long-Term IDR and senior unsecured notes at BB. Fitch positively assessed FY2025 EBITDA recovery, shortening of the working-capital cycle, the Advanta stake sale, and deleveraging through the rights issue. Constraints included Chinese manufacturing overcapacity, slow agrochemical price recovery, potential re-expansion of working capital in FY2026, and risk of financial deterioration from acquisitions or shareholder returns.

The stabilization of ratings indicates that UPL’s credit profile has moved away from the FY2024 stress phase. However, a BB rating means that, despite the company’s business scale, earnings volatility, working capital, liquidity, and financial policy risks remain higher than for investment-grade issuers. Based on the public information reviewed as of this report date, no new S&P/Fitch rating action after the FY2026 results announcement has been confirmed. How rating agencies reassess FY2026 debt repayment and leverage improvement within FFO/debt, liquidity assessment, working capital, and refinancing of the December 2026 maturity is an important item for the next review.

8. Credit Positioning

As a BB-rated global crop protection issuer, UPL is relatively strong in business scale, geographic diversification, and backward integration. However, it is weaker than higher-rated global chemical and agricultural solutions companies in patented-product mix and margin resilience. Fitch’s peer discussion places UPL in the same rating band as Nufarm, with advantages in product balance, Latin America presence, EBITDA scale, and margin, while identifying gaps versus higher-rated companies such as Syngenta and FMC in patented products, parent support, profitability, and coverage.

As an Indian issuer, UPL has global revenue that is not dependent solely on domestic demand. At the same time, this exposes it to FX, country-level regulations, farmer credit in multiple regions such as Brazil, the U.S., and Europe, logistics, and tariffs. From a fund manager’s perspective, UPL should be treated not as a simple Indian domestic-demand credit, but as a BB corporate with exposure to both the global agrochemical cycle and Indian corporate group structure.

Within the BB category, UPL’s business foundation is not weak. Its global sales network, backward integration, product diversification, and regional diversification are clearly stronger than those of local agrochemical companies or single-region chemical companies. FY2026 debt reduction also works in the direction of restoring rating headroom. On the other hand, liquidity quality, cash conversion, past accident and environmental issues, and post-patent price competition are constraints versus higher-rated peers. In other words, UPL is the type of issuer whose business scale appears stronger than BB, but whose financial risk and cash-flow volatility pull it back into the BB category.

For portfolio use, UPL is better viewed as exposure to the global agricultural inputs cycle than simply as diversification among Indian or Asian industrial credits. Agricultural commodity prices, Brazilian farmer credit, Chinese chemicals supply, U.S. and European regulation, Indian capital markets, and Middle East energy and logistics all affect the credit simultaneously. Looking only at country risk would misidentify the source of risk. Conversely, when these cycles improve and cash conversion is confirmed, UPL can capture improvement potential within the same rating band.

Market spread, specific bond tenor, price, call features, and subordination have not been obtained, so this report does not judge relative value. From a credit perspective alone, FY2026 improvement strengthens the case for holding and continued monitoring, but investment merit requires confirmation of bond-level spreads and covenant package.

9. Key Credit Strengths and Constraints

The first key credit support is UPL’s global crop protection franchise. Sales across more than 140 countries, a large position in the post-patent market, and product and regional diversification increase resilience to single-market shocks.

The second is financial improvement in FY2025-FY2026. EBITDA margin improved from 12.8% in FY2024 to 18.5% in FY2026, and net debt declined from USD 2.021 billion at FY2025-end to USD 1.616 billion at FY2026-end. Operating cash flow and FCFF also remained positive, consistent with stabilization of the rating outlook.

The third is access to capital and bank markets. The company’s ability to combine a rights issue, Advanta stake sale, refinancing, and debt repayment to repair the balance sheet after stress is an important support within the rating category.

The first constraint is the agrochemical cycle and price competition. If Chinese oversupply, inventory cycles, low agricultural commodity prices, and pressure on farmer profitability coincide, volume, pricing, and collection can deteriorate at the same time.

The second is working capital. UPL’s customer base is global and seasonal, and receivables can become large in markets such as Latin America. In FY2026, net working capital days increased to 57 days, and non-recourse receivables factoring rose to INR 102.31 billion. Even if EBITDA increases, expanding inventory and receivables can make it difficult for FFO/debt and liquidity coverage to improve.

The third is structural and information-related constraints. Even if consolidated results improve, the value of UPL Corp. bonds may be affected differently if the legal ranking, guarantees, collateral, subsidiary restrictions, or post-reorganization cash flow attribution changes.

10. Downside Scenarios and Monitoring Triggers

The most basic downside scenario is one in which crop protection price recovery stalls and volume recovery is absorbed by inventory build. In this case, revenue may grow, but EBITDA margin would narrow, inventory and receivables would increase, and operating cash flow would decline. Rating agency metrics such as FFO/debt, Debt/EBITDA, interest coverage, and FCF would deteriorate first.

The second downside is deterioration in farmer income and channel credit. If low agricultural commodity prices, adverse weather, higher interest rates, and weaker currencies coincide, farmers and distributors may delay input purchases, shift to lower-priced products, and extend payment terms. For UPL, this is likely to appear in receivables collection, credit costs, inventory adjustments, and short-term funding needs before it appears as a simple decline in demand.

The third downside is the Middle East / fertilizer and resource shock specifically flagged by the user. In March 2026, CRISIL stated that if Middle East issues persist, Indian domestic complex fertilizer and urea production could decline by 10-15%, citing dependence on LNG, ammonia, phosphate rock, and imported DAP/urea. The World Bank’s April 2026 Commodity Markets Outlook also stated that the Middle East war was pushing up energy and fertilizer prices. This is not a direct fertilizer production stoppage risk for UPL, but it can spread to crop protection demand and working capital through farmers’ input costs and government subsidy burdens.

Risk layer Direct relevance to UPL Credit impact Indicators to monitor
1. Fertilizer feedstock and fertilizer production stoppage: supply concerns for LNG, ammonia, phosphate rock, DAP, and urea Low Because UPL is not a fertilizer producer, the risk that fertilizer plant shutdowns directly stop UPL’s production is limited. Fertilizer prices, Indian fertilizer stocks, government import contracts, Kharif season supply conditions.
2. UPL’s own crop protection raw materials, chemical intermediates, logistics, and inventory Moderate Higher oil, gas, chemicals, and seaborne freight costs can pressure procurement costs, delivery delays, inventory build, gross margin, and working capital. Freight rates, raw material prices, inventory days, gross margin, manufacturing utilization, regional supply delays.
3. Farmer purchasing power, distributor credit, regional demand, and receivables collection Indirect but credit-important Higher fertilizer costs or weaker planting profitability can lead to delayed agrochemical purchases, shift to lower-priced products, higher channel inventories, and slower receivables collection. Agricultural commodity prices, farmer cash margins, regional sales, Latin America receivables, bad debt, working capital days.
4. Indian government fertilizer inventories and subsidy response Mitigant Can limit domestic farm-gate shortages and support farmers’ input demand. Does not buffer overseas markets. PIB fertilizer inventory releases, subsidy payments, P&K fertilizer agreements, import arrangements.
5. Deterioration in global farmer profitability Moderate to high In regions with weaker government buffers such as Latin America, receivables, credit, and inventory risk may rise before sales volume declines. Regional receivables, credit loss, inventory ageing, sales terms, distributor inventories.

Looking only at India, the PIB / Department of Fertilizers stated on March 6, 2026 that fertilizer inventories before the Kharif season had reached 177.31 LMT, 36.5% higher year on year, and that stocks and import arrangements for urea, DAP, and NPK could absorb supply shocks. This is a mitigating factor for UPL’s Indian business. However, UPL is a global company, and farmers in Brazil, Europe, North America, and other emerging markets are not protected by Indian government inventory and subsidy measures. Therefore, Middle East developments should be monitored less as a risk that “crop protection demand in India immediately collapses,” and more as a risk that fertilizer, energy, logistics, and farmer credit become unstable globally, weakening UPL’s cash conversion.

The sequence by which this shock would translate into credit deterioration is likely to be: first prices and logistics, then inventory and receivables, and finally earnings and leverage. For example, if logistics disruption around Hormuz or the Red Sea persists, not only fertilizer but also chemicals, packaging, and finished-product transport lead times could lengthen. The company may increase inventory to avoid shortages, in which case working capital could deteriorate even if revenue is maintained. Next, if fertilizer costs reduce farmers’ cash margins, distributors may seek longer payment terms. Finally, if mix shifts toward lower-priced products or inventory valuation losses emerge, EBITDA margin would fall. Credit monitoring should therefore look for balance sheet signals before income statement deterioration, based on this sequence.

There are also mitigating factors. In India, government inventories, long-term import contracts, fertilizer subsidies, and priority gas allocation may limit input shortages for farmers. If agricultural commodity prices offset higher fertilizer and logistics costs, farmers may be less likely to cut crop protection spending. UPL’s regional diversification also provides some ability to absorb shocks in specific markets at group level. It is therefore more realistic to treat a Middle East shock not as a standalone downgrade-level risk, but as a risk factor that becomes material if it coincides with price competition, renewed working capital expansion, and a weaker refinancing environment.

Monitoring items are FY2027 volume and price/mix, EBITDA margin, net working capital days, receivables, inventory, gross and net debt, FCF, rating agency reviews after FY2026 results, the creditor perimeter after reorganization, short-term maturities and refinancing, fertilizer prices and Indian government inventories, and Middle East / Hormuz / Red Sea logistics risk.

11. Credit View and Monitoring Focus

UPL’s current credit quality has clearly improved from the FY2024 stress phase, but it is not an investment-grade-like stable company. It is better viewed as a BB corporate exposed to the agrochemical cycle and working capital volatility. The direction of credit quality is modestly improving after the FY2026 audited results, but the pace of improvement should not be overstated because operating cash flow declined from FY2025 and working capital turned into a cash outflow. The probability of rapid near-term credit deterioration is not currently high, but this is a provisional view based on known information: reduced gross debt and net debt, cash and current investments of USD 0.709 billion, short-term debt of USD 0.687 billion, and proactive refinancing steps for the USD 0.5 billion maturity due in December 2026. Unused lines, 12-month sources/uses, and a detailed maturity schedule have not been obtained. If the factoring market, receivables collection including in Latin America, and agrochemical prices deteriorate simultaneously, this view should be revised quickly.

FY2026 revenue, EBITDA, net profit, and net debt/EBITDA support the post-stabilization improvement in the rating outlook. In particular, the USD 0.5 billion debt repayment, USD 0.85 billion reduction in gross debt, USD 0.405 billion reduction in net debt, and FCFE of INR 32.26 billion are more significant for credit than simple profit recovery. At the same time, the ceiling on credit quality is constrained by post-patent agrochemical price competition, working capital volatility, factoring usage, regional collection including Latin America, and unconfirmed structural and guarantee information. For UPL, even if the income statement improves, liquidity and FCF weaken quickly if inventories and receivables rise.

The next review should assess whether net working capital days expand again in FY2027, whether DSO and non-recourse factoring continue to increase, how far rating agency-adjusted leverage differs from company-disclosed ratios, and on what terms the December 2026 sustainability-linked loan bonds are refinanced. In addition, improvement in consolidated UPL Limited or EBITDA recovery at the UPL Corp management platform should not be equated with the standalone issuer financials of UPL Corporation Ltd. or the legal protections of UPL Corp. bonds. Explicit guarantees, guarantor scope, collateral, subsidiary restrictions, covenants, and the creditor perimeter after the Composite Scheme of Arrangement need to be checked separately.

Fertilizer and resource risks from Middle East developments are a central issue, but for UPL the channel is indirect. More important than the risk of direct production stoppage from LNG or ammonia shortages, as would be the case for fertilizer producers, is the risk that higher fertilizer prices pressure farmers’ cash margins and spread into crop protection purchases, receivables, inventory, and regional sales collection. Indian government inventories and import arrangements are mitigating factors domestically, but they are not a sufficient buffer for UPL’s global revenue base.

For bond investors, UPL at this stage is a candidate for holding and continued monitoring after confirmed improvement, and is easier to handle from a credit perspective than during the FY2024-FY2025 stress period. However, new investment should be decided only after reviewing UPL Corp. bond terms, maturities, guarantees, and—if available—market levels and relative value. The credit base case is improving, but if fertilizer, energy, and logistics shocks persist, FY2027 FCF, DSO, inventories, factoring, and short-term refinancing will be the first warning indicators.

12. Short Summary & Conclusion

UPL is an India-origin global crop protection company. Its audited FY2026 full-year materials show improvement across revenue, EBITDA, net profit, and debt reduction. The credit view is improving, but UPL remains a BB credit exposed to price competition and working capital volatility. The most important monitoring points are FY2027 cash conversion, short-term refinancing, legal protection for UPL Corp. bondholders, and the secondary effects of Middle East developments on farmer purchasing power and receivables collection.

13. Sources

13.1 Key Primary Sources

13.2 Rating Agency Materials

13.3 Supplementary Materials

13.4 Limitations Already Reflected in This Conclusion

13.5 Items to Review Before Specific Bond Investment / Next Update